![Beth Weinberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Beth Weinberg
Consejero General en CARA THERAPEUTICS, INC. .
Cargos activos de Beth Weinberg
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CARA THERAPEUTICS, INC. | Consejero General | - | - |
Historial de carrera de Beth Weinberg
Antiguos cargos conocidos de Beth Weinberg.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ANGN BIOM | Consejero General | - | - |
Metavant Sciences, Inc. | Consejero General | - | - |
Formación de Beth Weinberg.
Bradley University | Undergraduate Degree |
Butler University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
General Counsel | 3 |
Undergraduate Degree | 2 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CARA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Metavant Sciences, Inc. | |
Angion Biomedica Corp.
![]() Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Beth Weinberg
- Experiencia